To evaluate the effects of the combining transcranial direct current stimulation with core stability exercises on trunk performance in poststroke hemiparetic patients, the secondary outcome is to evaluate the balance and the functional performance of the participants.
Eligibility
Sex
ALL
Min age
55 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients will be included if they are ≥ 55 years old of both sex, had a first-time right or left stroke within the preceding six months that damaged the cerebral cortex verified by (computed tomography or MRI report, neurological examination, and medical chart).
* Patients can stand and walk independently.
* Modified Ashworth Scale (MAS) of upper limb muscle ≤ 1+.
* All the patients received a conventional physiotherapy program in the acute stage and post-discharge from the hospital.
* None of the patients participated in any other study or placebo
Exclusion Criteria:
* Patients with neurological or orthopedic problems, paralysis neglect, behavioral abnormalities, dementia any shoulder dysfunction before or post-stroke (dislocation or subluxation), or those who using upper limb splints.
* Recurrent strokes or hemiparesis due to other neurological causes rather than stroke eg .(Brain tumor).
* Obesity (BMI ≥ 30 kg/m2).
Primary outcome measure(s)
Trunk Impairment Scale (TIS). — up to 8 weeks trunk performance will be assessed by Trunk Impairment Scale (TIS).
Berg Balance Scale — up to 8 weeks Balance will be assessed by berg balance scale, the balance score ranges from 0 to 56, with lower scores indicating increased risk of balance loss and higher scores indicating improved functional mobility. Time up and go test (TUG)n Score \< 10 seconds = normal \< 20 seconds = good mobility; can walk outside alone; does not require a walking aid \< 30 seconds = walking and balance problems; cannot walk outside alone; requires walking aid
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.